Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)

Infographics
Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)

This study provides you a brief insight on the efficacy and safety of intravesical BCG instillations when used in patients with Non-Muscle-Invasive Bladder Cancer, presenting with asymptomatic bacteriuria (ABU).

Related Content

Featured Content